Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11-Reference-Cited by-同舟云学术

Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11

Published:2015-03-26 Issue:14 Volume:6 Page:12156-12173
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zagryazhskaya Anna¹,Surova Olga¹²,Akbar Nadeem S.¹,Allavena Giulia¹³,Gyuraszova Katarina¹⁴,Zborovskaya Irina B.⁵⁶,Tchevkina Elena M.⁵⁶,Zhivotovsky Boris¹⁶

Affiliation:

1. Institute of Environmental Medicine, Division of Toxicology, Stockholm, Sweden

2. Ludwig Institute for Cancer Research Ltd, Karolinska Institutet, Stockholm, Sweden

3. Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy

4. Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Košice, Slovakia

5. NN Blokhin Russian Cancer Research Center, Moscow, Russia

6. Faculty of Fundamental Medicine, ML Lomonosov State University, Moscow, Russia

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Folding Stability Profiling of Colorectal Cancer Chemoresistance Identifies Functionally Relevant Biomarkers;Journal of Proteome Research;2023-05-01

2. Friend or Foe? The fascinating Tudor-SN protein;Visualized Cancer Medicine;2023

3. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis;Oncology Reports;2022-11-25

4. Exonic splicing code and protein binding sites for calcium;Nucleic Acids Research;2022-04-26

5. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics;Frontiers in Nanotechnology;2021-06-09